BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30229447)

  • 1. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
    Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
    Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
    Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
    Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
    Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
    Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
    Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
    Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
    Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
    Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
    Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
    Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
    Chobrutskiy BI; Zaman S; Tong WL; Diviney A; Blanck G
    J Neurooncol; 2018 Dec; 140(3):697-704. PubMed ID: 30382482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.
    Huda TI; Mihyu M; Gozlan EC; Arndt MF; Diaz MJ; Zaman S; Chobrutskiy BI; Blanck G
    Leuk Lymphoma; 2021 Jul; 62(7):1711-1720. PubMed ID: 33622167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.
    Zaman S; Chobrutskiy BI; Patel JS; Diviney A; Tu YN; Tong WL; Gill T; Blanck G
    Viral Immunol; 2020 Jun; 33(5):404-412. PubMed ID: 32315578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns.
    Callahan BM; Yavorski JM; Tu YN; Tong WL; Kinskey JC; Clark KR; Fawcett TJ; Blanck G
    Cancer Immunol Immunother; 2018 Jun; 67(6):885-892. PubMed ID: 29508024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens.
    Tu YN; Tong WL; Fawcett TJ; Blanck G
    Lab Invest; 2017 Dec; 97(12):1516-1520. PubMed ID: 28805806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
    Diaz MJ; Chobrutskiy BI; Zaman S; Blanck G
    Cancer Treat Res Commun; 2020; 24():100196. PubMed ID: 32769037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer.
    Tong WL; Tu YN; Samy MD; Sexton WJ; Blanck G
    Hum Vaccin Immunother; 2017 Mar; 13(3):501-506. PubMed ID: 28085544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes.
    Gozlan EC; Chobrutskiy BI; Blanck G
    Int J Lab Hematol; 2022 Oct; 44(5):883-891. PubMed ID: 35527672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.
    Kinskey JC; Tu YN; Tong WL; Yavorski JM; Blanck G
    Cancer Microenviron; 2018 Jun; 11(1):51-59. PubMed ID: 29404962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma.
    Cios KJ; Huda TI; Eakins RA; Mihyu MM; Blanck G
    Leuk Lymphoma; 2022 Jun; 63(6):1314-1322. PubMed ID: 35019822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates.
    Callahan BM; Tong WL; Blanck G
    Immunol Res; 2018 Apr; 66(2):219-223. PubMed ID: 29594966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune DNA signature of T-cell infiltration in breast tumor exomes.
    Levy E; Marty R; Gárate Calderón V; Woo B; Dow M; Armisen R; Carter H; Harismendy O
    Sci Rep; 2016 Jul; 6():30064. PubMed ID: 27452728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells.
    Mwangi KW; Kamita MK; Waweru JW; Sayed S; Figueroa JD; Ambs S; Cios KJ; Blanck G; Makokha FW
    Breast Cancer Res Treat; 2023 May; 199(1):207-214. PubMed ID: 36882607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations.
    Tu YN; Tong WL; Yavorski JM; Blanck G
    Cancer Microenviron; 2018 Jun; 11(1):41-49. PubMed ID: 29357011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.